EPISODE · Nov 5, 2025 · 6 MIN
Novo Nordisk CEO Mike Doustdar Talks Drug Sales
from Bloomberg Talks · host Bloomberg
Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far. See omnystudio.com/listener for privacy information.
Embed this episode
NOW PLAYING
Novo Nordisk CEO Mike Doustdar Talks Drug Sales
0:00
6:52
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Bloomberg Talks?
This episode is 6 minutes long.
When was this Bloomberg Talks episode published?
This episode was published on November 5, 2025.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this Bloomberg Talks episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!